Search results for nomura

AstraZeneca and Nomura Phase4 Ventures today announced the signing of a deal to form Albireo, a company focused on developing new treatments for gastrointestinal (GI) disorders. Albireo, based in read more »
Discuss   Add this link to...  Bury